tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Morten Herholdt, 9 are a BUY (64.29%), 3 are a HOLD (21.43%), 2 are a SELL (14.29%).
Analyst Morten Herholdt, currently employed at HSBC, carries an average stock price target met ratio of 30% that have a potential upside of 13.95% achieved within 323 days.
Morten Herholdt’s has documented 27 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AMGN, Amgen at 10-Sep-2026.
Analyst best performing recommendations are on GILD (GILEAD SCIENCES).
The best stock recommendation documented was for GILD (GILEAD SCIENCES) at 9/6/2023. The price target of $71 was fulfilled within 40 days with a profit of $4.11 (6.14%) receiving and performance score of 1.54.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell Since 17-Mar-2026
$175
$-44.88 (-20.41%)
$150
23 days ago
(10-Sep-2026)
0/3 (0%)
$-40.43 (-18.77%)
Buy Since 15-May-2026
$245
$25.12 (11.42%)
$225
1 months ago
(03-Sep-2026)
4/8 (50%)
$20.49 (9.13%)
76
Buy Since 04-Mar-2022
$260
$40.12 (18.25%)
$240
1 months 8 days ago
(25-Aug-2026)
57/87 (65.52%)
$39.23 (17.77%)
169
Buy Since 28-Sep-2022
$241
$21.12 (9.61%)
$221
1 months 29 days ago
(04-Aug-2026)
25/42 (59.52%)
$32.55 (15.62%)
152
Hold Since 06-Jan-2023
$215
$-4.88 (-2.22%)
$200
2 months ago
(03-Aug-2026)
29/38 (76.32%)
$13.18 (6.53%)
220
Which stock is Morten Herholdt most bullish on?
Which stock is Morten Herholdt most reserved on?
What Year was the first public recommendation made by Morten Herholdt?
